Article
A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing.
Nature chemistry - 1 Nov 2022
Taylor Alexander I, Wan Christopher J K, Donde Maria J, Peak-Chew Sew-Yeu, Holliger Philipp
Abstract excerpt
Nucleic-acid catalysts (ribozymes, DNA- and XNAzymes) cleave target (m)RNAs with high specificity but have shown limited efficacy in clinical applications. Here we report on the in vitro evolution and engineering of a highly specific modular RNA endonuclease XNAzyme, FR6_1, composed of 2'-deoxy-2'-fluoro-β-D-arabino nucleic acid (FANA). FR6_1 overcomes the activity limitations of previous DNA- and XNAzymes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
